Show results for
Refine by
Colorectal Cancer Equipment Supplied In Europe
39 equipment items found
Manufactured by:Tonix Pharmaceuticals Holding Corp. based inChatham, NEW JERSEY (USA)
TNX-1700 is a stabilized recombinant version of Trefoil Factor 2 (TFF2) and is being developed by Tonix as a biologic to treat gastric and colorectal cancers. TFF2 is a small, secreted protein, encoded by the TFF2 gene in humans that is expressed in gastrointestinal mucosa where it functions to protect and repair mucosa. TFF2 is also expressed at low levels in ...
Manufactured by:Molecular Devices, LLC. based inSan Jose, CALIFORNIA (USA)
Derived from patient tissue our colorectal cancer organoids are available from a range of sites and TNM stages. They cover varied morphologies and growth ...
Manufactured by:Epigenomics AG based inBerlin, GERMANY
Colorectal cancer is curable in about 90% of cases if detected early. Nevertheless, this disease is one of the most frequent causes of cancer-related deaths in the industrialized world. Regular screening can prevent colorectal cancer. Epi proColon® offers a convenient way of detecting ...
Manufactured by:OncoDiag based inMiserey, FRANCE
An accurate blood-based test for the screening of colorectal cancer ...
Manufactured by:PREVENTIS GMBH based inBensheim, GERMANY
The immunological occult blood test PreventID® CC is a rapid test for self-testing for the qualitative detection of the valuable red blood pigment hemoglobin in stool as a marker for intestinal bleeding. The result can be read after 10 minutes. According to the WHO, colorectal cancer is the third most common cancer worldwide, with ...
by:Debiopharm based inLausanne, SWITZERLAND
It is the active substance of the branded Eloxatin®/Elplat®/Dacotin®/Dacplat®, which has dramatically changed the prognosis of colorectal cancer. In 1996, prior to the introduction of oxaliplatin, the standard of care for colorectal cancer was 5-fluorouracil (5-FU). Combination of oxaliplatin with 5-FU and ...
Manufactured by:Vitrosens Biotechnology A.S. based inÜmraniye, TURKEY
Test kit is created for the qualitative detection of Hemoglobin (HGB) in human fecal samples. It enables early detection of lower gastrointestinal. disorders, such as colorectal cancers and ...
Manufactured by:Amadix based inValladolid, SPAIN
PreveCol, an innovative blood-based test for early colorectal cancer detection. PreveCol is an innovative test based on an algorithm that combines the clinical characteristics identified by Artificial Intelligence with the analysis of biomarker levels in plasma for the early detection of Colorectal Cancer (CRC) and advanced ...
Manufactured by:PREVENTIS GMBH based inBensheim, GERMANY
The detection of hemoglobin in stool can be used as a marker for gastrointestinal bleeding for colorectal cancer screening. Blood in the stool can come from tumors or polyps in the intestine, among other sources. If hemoglobin has been detected, a colonoscopy must be performed to determine whether the bleeding is actually from a tumor or a precancerous lesion. ...
Manufactured by:Olympus Europa SE & Co. KG based inHamburg, GERMANY
ENDO-AID CADe is a computer-aided detection application that uses AI to suggest the potential presence of lesions such as colonic polyps, malignant neoplasms and adenomas. An increase in ADR (adenoma detection rate) and therefore an improvement in the prevention of colorectal cancer (CRC) is supported when using CADe during coloscopic ...
Manufactured by:BioMaxima SA based inLublin, POLAND
BioMaxima was the first in Poland to start production of rapid diagnostic tests. The most popular and flagship product is the fecal occult blood test used for the diagnosis of colorectal cancer. We offer tests for infectious diseases, inflammatory and cancer markers and addictive drugs. Every year, based on the requirements of customers, we are ...
Manufactured by:Salofa Oy based inSalo, FINLAND
The FOB test measures the condition of the gastrointestinal tract by detecting haemoglobin in the blood of a stool sample. The test is suitable for detecting intestinal bleeding and helps, for example, in diagnosing colorectal cancer. The test package includes a disposable test cartridge. ...
by:F. Hoffmann-La Roche Ltd. based inBasel, SWITZERLAND
Avastin is a monoclonal antibody that targets vascular endothelial growth factor A (VEGF-A). With the initial approval in the United States for advanced colorectal cancer in 2004, Avastin became the first anti-angiogenic therapy made widely available for the treatment of patients with an advanced ...
by:Pure Biologics SA based inWroclaw, POLAND
Colorectal cancer (CRC) is the second-most common cancer diagnosed in women and third-most in men. Based upon five-year survival rates, chances of becoming cured remain to be approximately 65%. Therapies targeting immunological checkpoints, or more specifically their inhibition, promise effective treatment options for patients with metastatic ...
Manufactured by:SurgiMab based inMontpellier, FRANCE
SGM-101, currently in Phase III for the delineation of primary and recurrent tumor and metastases in patients undergoing surgery for colorectal cancer, is a tumor-specific antibody conjugated to a near-infrared fluorochrome. It selectively binds a specific marker overexpressed in gastrointestinal and other ...
Manufactured by:ORYX GmbH & Co. KG based inBaldham, GERMANY
Several cancers arise from the lack of DNA mismatch repair (MMR) resulting in the accumulation of thousands of single deletions or insertions at coding microsatellites (MSI-H). These mutations lead to the inactivation of specific proteins and to the expression of frameshift peptides (FSPs). These FSPs are tumor-specific antigens, which are constantly expressed. ...
Manufactured by:Treos Bio Limited based inLondon, UNITED KINGDOM
In silico trials predicted that these peptides induce exceptionally broad T cell responses against at least 3 tumor-specific antigens in high proportion of patients, without need of biopsy. Phase 1 clinical study is completed to confirm the predictions in patients with metastatic colorectal cancer (NCT03391232, Hubbard et al ASCO 2020). ...
Manufactured by:ViennaLab Diagnostics GmbH based inVienna, AUSTRIA
BRAF encodes a serine/threonine protein kinase, which plays an important role in signaling pathways involved in cell proliferation and differentiation. Determination of BRAF V600 mutational status is recommended in metastatic colorectal cancer (mCRC) at the same time as RAS mutational status for prognostic assessment (and/or potential selection for clinical ...
Manufactured by:BIOHIT Healthcare Ltd based inEllesmere Port, UNITED KINGDOM
The detection of haemoglobin in stool samples can be used as a marker of gastrointestinal bleeding as part of a colorectal cancer screening initiative. Hidden traces of blood in the stool can originate from tumours or polyps (lesions) in the lower gastrointestinal tract so when haemoglobin is detected in stool samples it is indicative of the presence of such ...
Manufactured by:Elthera AG based inSchlieren, SWITZERLAND
L1 cell adhesion molecule (L1CAM) is a cell surface protein which is aberrantly expressed in many different tumor types including pancreatic, ovarian, breast, lung, and colorectal cancer. L1CAM expression increases the malignancy of these tumors by promoting cellular proliferation, metastatic spread, tumor angiogenesis, and resistance to chemotherapy. ...